Tiziana Life Sciences (TLSA) Retained Earnings (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Retained Earnings for 9 consecutive years, with $118.7 million the latest figure, recorded in Q4 2025.

• Quarterly Retained Earnings changed 0.0% year-over-year to $118.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $118.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $118.7 million, changed 0.0% from the prior year.
• Retained Earnings steadied at $118.7 million in Q4 2025 per TLSA's latest filing, from $118.7 million in the prior quarter.
• Over the last five years, Retained Earnings for TLSA reached as high as $118.7 million in Q2 2024 and fell as low as $118.7 million in Q2 2021.
• A 5-year average of $118.7 million and a median of $118.7 million in 2021 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2021 — Retained Earnings soared 301.97% — and 2022, when it changed 0.0%.
• Year by year, Retained Earnings stood at $118.7 million in 2021, then changed by 0.0% to $118.7 million in 2022, then changed by 0.0% to $118.7 million in 2023, then changed by 0.0% to $118.7 million in 2024, then changed by 0.0% to $118.7 million in 2025.
• According to Business Quant data, Retained Earnings over the past three periods registered $118.7 million, $118.7 million, and $118.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.